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non-randomized study.  Conclusions: When a randomized 
controlled trial is not possible, this quasi-experimental de-
sign using the PS could be a feasible alternative. Its advan-
tages and limitations are discussed. Implemented carefully, 
this method is promising for future effectiveness research. 
 Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 The first randomized study in medicine was conducted 
by Amberson  [1]  in 1931 by flipping a coin. Now, random-
ized controlled trials are considered the gold standard for 
comparing the effectiveness of psychotherapeutic treat-
ment methods. Randomization assumes that all known 
and unknown characteristics of the participants are bal-
anced between the experimental groups, except for the 
treatment condition. With randomization, treatment ef-
fects can theoretically be estimated by merely subtracting 
the mean responses of the treatment groups  [2] . In many 
cases, though, randomization may be difficult, unethical 
or impossible  [3] , especially in psychotherapy research
 [4–7] . Here patients’ and clinicians’ personal preferences 
regarding treatment allocation may work against ran-
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 Abstract 
 Background: Randomized controlled trials are considered 
the best scientific proof of effectiveness. There is increasing 
concern, though, about their feasibility in psychotherapy re-
search. We discuss a quasi-experimental study design for 
situations in which a randomized controlled trial is not fea-
sible. Here, as an alternative strategy, the propensity score 
(PS) method is used to correct for selection bias.  Methods: 
We used data from a Dutch research project, SCEPTRE (Study 
on Cost-Effectiveness of Personality Disorder Treatment). 
The sample consisted of 749 psychotherapy patients with 
personality pathology. We tested whether the PS method 
was useful and applicable. We examined differences be-
tween 2 treatment groups (short vs. long treatment dura-
tion) in pretreatment characteristics before and after PS cor-
rection. This revealed the impact of the PS on outcome 
differences.  Results: The PS offered statistical control over 
observed pretreatment differences between patients in a 
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domization. The resulting high number of excluded sub-
jects makes the generalization of such results difficult
 [8] . Hence, research on treatment effects in various 
(para)medical fields often requires well-designed and 
carefully conducted non-randomized studies [e.g. 9, 10 ]. 
Shadish et al.  [11] called these studies ‘quasi-experimental’, 
based on their resemblance to true experiments, except for 
the random assignment of participants to treatments. In 
these quasi-experimental designs, the researcher has some 
influence on the manipulation of treatment and measure-
ment. This is in contrast to pure observational studies, 
where the size and direction of a relationship among vari-
ables are simply observed  [11] . In case of non-random al-
location to treatment, persons with different treatments 
can differ on pretreatment characteristics. This ‘selection 
bias’ affects the estimates of the treatment effect. Rosen-
baum  [12] distinguishes 2 types of bias: hidden bias, due 
to unobserved differences in baseline characteristics, and 
overt bias, due to observed differences in baseline charac-
teristics. Hidden bias is the most difficult to deal with. 
Overt bias can be corrected with various statistical meth-
ods, by incorporating known initial differences into the 
statistical analysis. The most widely used methods are 
matching, stratification and regression adjustment  [13–
15] . In matching, each individual in the treatment group 
is paired with the most similar individual in the control 
group. After matching, the groups as a whole are assumed 
to be as similar as possible on the matched characteristics. 
In stratification, subgroups of patients are formed based 
on baseline variables. In psychotherapy research, however, 
there is usually a large number of variables to match or 
stratify on, making it almost impossible to find patients or 
groups similar on all these variables. This is called the ‘di-
mensionality problem’. Regression analysis with covari-
ates, a third tool to compensate for overt bias, has limita-
tions as well: when many pretreatment variables are used 
as covariates, statistical-modelling problems and a loss of 
power arise. A promising alternative method to correct for 
overt bias is the propensity score (PS) method  [12, 16] .
 Propensity Score 
 Rosenbaum and Rubin  [16] suggested using the PS 
method to reduce the ‘dimensionality problem’. The PS 
method reduces the entire collection of observed pretreat-
ment variables (X) to a single score. The estimated PS is 
defined as the conditional probability of assignment to a 
particular treatment, given a set of observed pretreatment 
characteristics. Let Z denote treatment group member-
ship, where Z = 0 denotes the control condition and Z = 1 
denotes the treatment condition. Then, PS is defined as:
 PS = P(Z = 1   X)
 Rosenbaum and Rubin  [16] proved that, given the value 
of the PS, assignment to treatment no longer depends on 
baseline variables. The PS is a score balancing all observed 
pretreatment variables among patients with the same val-
ue of the PS. In this way, the PS method can put overt bias 
under statistical control. Different from the conventional 
approach, i.e. controlling for or matching on many base-
line variables, the PS enables researchers to deal with one 
composite, single variable which is much easier and, in 
regression analysis, preserves power. The PS has so far 
been used in medicine [e.g.  17–24 ], social sciences [e.g. 
 25–28 ] and economics [e.g.  29–31 ]. The United States 
Food and Drug Administration recommended the PS as 
a tool to overcome selection bias in treatment studies  [32] . 
In psychotherapy research, however, the PS is not widely 
known. To the best of our knowledge, only a handful of 
pioneering studies have used this instrument for selection 
bias control in non-randomized studies  [33–36] .
 Aim 
 The aims of this paper are (1) to investigate if the PS 
method is applicable in psychotherapy research and (2) to 
outline a step-by-step protocol for the psychotherapy re-
searcher to facilitate use of the PS in comparative out-
come studies when randomization is unfeasible. We ap-
plied the PS method to a case study, the research project 
SCEPTRE (‘Study on Cost-Effectiveness of Personality 
Disorder Treatment’)  [37] . We compared 2 treatment 
groups from SCEPTRE, using the PS to correct for known 
baseline differences. The 2 treatment groups selected for 
comparison are short versus long psychotherapy dura-
tion, as this distinction is straightforward and simple to 
understand. Results should only be interpreted as an il-
lustration, not as a relevant clinical message. All statisti-
cal techniques presented in this paper are easily done in 
common statistical packages, such as SPSS.
 Method 
 Participants 
 Patients were recruited from 6 mental health care centres in 
the Netherlands offering outpatient, day hospital and/or inpatient 
psychotherapy for patients with personality pathology. Out of 
2,540 patients who were admitted to the centres from March 2003 
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to March 2006, 1,047 were selected for treatment, i.e. short- or 
long-duration psychotherapy in various settings. Before treat-
ment allocation, all patients were assessed with a routinely dis-
tributed assessment battery including self-report questionnaires. 
A semistructured interview was conducted to diagnose personal-
ity disorders with DSM-IV criteria. Of the 1,047 patients selected 
for treatment, 298 patients had not yet completed a follow-up 
measure, so no outcome score could be calculated. These were 
excluded from the analyses, leaving 749 patients. Of these, 507 
(67.7%) were female. The mean age was 34.24 years (SD 9.93, range 
17–62). We divided this sample into 2 groups: one group allocated 
to short-term therapy (up to 6 months), the other group allocated 
to long-term therapy (more than 6 months).
 Measures 
 The baseline assessment measured a long list of social, eco-
nomic and diagnostic variables carefully selected by both clini-
cians and researchers, based on literature and clinical knowledge 
(see  tables 1 and  2 ).
 Psychiatric symptomatology was measured with the Symptom 
Checklist 90 Revised, Dutch version (SCL-90)  [38–40] . In this 
study, we used the Global Severity Index of the SCL-90 (GSI; the 
mean score of all 90 items) as the primary outcome measure, with 
higher scores indicating more distress. To measure the type and 
degree of personality pathology we used the 4 higher-order fac-
tors of the Dimensional Assessment of Personality Pathology Ba-
sic Questionnaire, Dutch version (DAPP-BQ)  [41, 42] : (1) emo-
tional dysregulation, (2) dissocial behaviour, (3) inhibition and (4) 
compulsivity. Psychosocial functioning was measured with the 
Outcome Questionnaire 45, Dutch version (OQ-45)  [43] . Of this 
self-report measure, we used 2 subscales: (1) interpersonal rela-
tions and (2) social-role functioning. Health-related quality of life 
was assessed with the EuroQoL EQ-5D  [44] . Personality disorders 
were assessed with the Structured Interview of DSM-IV Personal-
ity, Dutch version (SIDP-IV)  [45–47] . The severity of personality 
pathology was measured with 5 higher-order domains of the Se-
verity Indices of Personality Problems (SIPP)  [48, 49] : self-con-
trol, social concordance, identity integration, relational function-
ing and responsibility. To measure patients’ motivation for treat-
ment, we used the two scales of the Motivation for Treatment 
Questionnaire (MTQ-8)  [50] : need for help and readiness to 
change.
Table 1. Differences in continuous variables between short-term and long-term treatment groups
Variable Short term
(n = 331)
Long term
(n = 328)
Unstandardized 
treatment duration
(short/long)
before PS
correction
after PS
correction
Age, years 36.8389.63 31.8689.49 –4.97*** –0.10
Personality pathology (DAPP-BQ)
Emotional dysregulation 21.9384.02 22.8783.66 0.95** 0.05
Dissocial behaviour 17.3584.10 18.0184.40 0.66* 0.09
Inhibitedness 22.1185.06 22.5184.97 0.40 0.03
Compulsivity 24.2986.84 23.8787.29 –0.42 –0.18
Motivation (MTQ-8)
Need for help 28.8785.23 28.4685.22 –0.41 –0.02
Readiness to change 30.7085.04 29.9685.16 –0.74 –0.53
Quality of life (EQ-5D) 0.5980.26 0.5580.26 –0.04 –0.00
Psychological capacities (SIPP)
Self-control 4.6580.91 4.4880.90 –0.17* –0.03
Social concordance 5.7280.78 5.6380.81 –0.09 –0.03
Identity integration 3.5480.71 3.3880.65 –0.16** –0.01
Relational functioning 3.9780.84 3.7980.78 –0.17** –0.02
Responsibility 4.6780.84 4.5280.88 –0.14* –0.02
Psychiatric symptomatology (SCL-90) 2.3980.62 2.5580.65 0.16** 0.01
Functioning (OQ-45)
Interpersonal functioning 20.0786.29 21.6086.01 1.54** –0.01
Social role functioning 15.2884.86 15.5984.58 0.32 0.06
Axis-II diagnosis (SIDP-IV)
Number of Axis-II cluster A disorders 0.0480.19 0.0980.29 0.05* 0.01
Number of Axis-II cluster B disorders 0.1980.48 0.3480.58 0.15*** 0.03
Number of Axis-II cluster C disorders 0.6580.78 0.7080.79 0.05 0.03
Duration of psychological problems 3.5980.81 3.5980.79 0.00 0.04
Values are presented as means 8 SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
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Table 2. Differences in categorical variables between short-term and long-term treatment groups
Variable Demographic data, % Odds ratio treatment duration (short/long)
short term
(n = 331)
long term
(n = 328)
before PS
correction
after PS
correction
Gender
Female 65.3 68.9 1.00a 1.00a
Male 34.7 31.1 1.18 1.01
Civil status
Married 27.5 18.0 1.00a 1.00a
Widowed or divorced 13.3 10.1 0.86 1.07
Never married 59.2 72.0 0.54** 1.04
Living situation
Alone 39.0 38.4 1.00a 1.00a
With partner (with or without child) 44.4 29.3 1.50* 0.98
With child without partner 5.7 6.4 0.88 1.02
With parent(s) 4.2 17.7 0.24*** 1.14
With other people 6.6 8.2 0.80 1.02
Childcare
No care for children 72.5 80.5 1.00a 1.00a
Care for children 27.5 19.5 1.56* 0.95
Work situation
Unemployed 33.2 36.3 1.00a 1.00a
Study or paid work 66.8 63.7 1.14 0.99
Level of education
Low 19.3 28.0 1.00a 1.00a
Middle 22.7 17.7 1.86** 0.94
High 58.0 54.3 1.55* 0.89
Previous outpatient treatment
No 17.2 22.6 1.00a 1.00a
Yes 82.8 77.4 1.40 1.00
Previous inpatient treatment
No 83.4 79.9 1.00a 1.00a
Yes 16.6 20.1 0.79 1.03
Previous medication treatment
No 53.8 52.7 1.00a 1.00a
Yes 46.2 47.3 0.96 1.17
Alcohol abuse
No 84.5 87.2 1.00a 1.00a
Yes 15.5 12.8 1.25 0.80
Drug abuse
No 86.1 77.4 1.00a 1.00a
Yes 13.9 22.6 0.55** 1.10
Preference for treatment setting
Outpatient 12.1 22.9 1.00a 1.00a
Day hospital 30.9 24.8 2.36*** 0.68
Inpatient 35.5 29.4 2.29** 0.85
Do not know 21.5 22.9 1.78* 0.67
Preference for treatment duration
Up to 6 months 43.5 25.3 1.00a 1.00a
Longer than 6 months 26.9 37.2 0.42*** 0.99
Do not know 29.6 37.5 0.46*** 1.04
Treatment setting
Outpatient 18.7 34.1 1.00a 1.00a
Day hospital 31.7 30.2 1.92** 0.99
Inpatient 49.5 35.7 2.53*** 0.96
* p < 0.05, ** p < 0.01, *** p < 0.001.
a Category is reference category; for regression purposes all categorical variables were translated into dummy variables, whereby the first category 
always serves as a reference category with an odds ratio of 1.00.
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 Results 
 To avoid bias in the estimation of the treatment effect, 
we corrected for the influence of known pretreatment 
differences. We did this by stratification of the sample 
based on the PS. This process took 9 steps, described be-
low. 
 Stratification 
 Step 1: Effect Estimation before Correction 
 Before correction for known pretreatment differences, 
we estimated the treatment effect by conducting a linear 
regression analysis. In this ‘naïve’ estimate the only inde-
pendent variable was ‘group membership’ (short vs. long), 
the dependent variable was outcome, being defined here 
as the level of psychiatric symptomatology (GSI) at the 
first measurement following baseline. The uncorrected 
treatment effect   was 0.20 (SE = 0.05; p  ! 0.001).
 Step 2: Balance Check before Correction 
 We compared the 2 treatment groups on pretreatment 
variables before stratification. Note that this step is nei-
ther relevant for variable selection for the PS, nor for fur-
ther analyses. It is only important here to be able to dem-
onstrate the influence of propensity correction on the 
balance between groups. This demonstration can be done 
in several ways. For illustration purposes, we chose to 
show a comparison of overall regression coefficients. We 
conducted a number of regression analyses with ‘group 
membership’ as an independent variable and pretreat-
ment characteristics as dependent variables (linear re-
gression analyses for continuous variables, see  table 1 , 
and multinomial logistic regression analyses for categor-
ical variables, see  table 2 ). The 2 patient groups (short- vs. 
long-term treatment) differed significantly on 19 of the 
34 baseline variables. This implies that, without correc-
tion for these differences, the 2 groups were not readily 
comparable – a problem that may be dealt with using the 
PS. 
 Step 3: Variable Selection for PS Estimation 
 To estimate the PS, we used all baseline variables re-
lated to outcome (GSI). To identify related variables, we 
conducted a number of linear regression analyses with 
the GSI as the dependent variable and each potential con-
founder as an independent variable. The following vari-
ables emerged as primary candidates for the estimation 
of the PS: level of personality pathology (i.e. emotional 
dysregulation, dissocial behaviour and inhibitedness), 
motivation for treatment (i.e. need for help), quality of 
life, psychological capacities (i.e. self-control, social con-
cordance, identity integration, relational functioning and 
responsibility), level of psychiatric symptomatology, 
functioning (i.e. interpersonal and social-role function-
ing), number of cluster A, B and C personality disorders, 
working situation, level of education, previous inpatient 
treatment, patient preferences for treatment duration and 
setting of treatment. Sociodemographic variables were 
added to the PS model as well, because they are consid-
ered highly relevant in psychotherapy research: age, gen-
der, marital status, living situation and responsibility for 
the care of children.
 Step 4: Exclusion of Incomplete Cases 
 In this example, only patients with no missing values 
on the selected potential confounders (see ‘Step 3’) were 
included in the PS analysis. The final sample therefore 
consisted of 659 patients. Alternatively, imputation tech-
niques might be used to fill in the missing values in esti-
mation variables.
 Step 5: PS Estimation 
 The PS was estimated in a logistic regression analysis. 
All selected potential confounders were used as indepen-
dent variables, and ‘group membership’ as the dependent 
variable. One can estimate and save these probabilities 
for each subject, e.g. by using the option ‘save predicted 
probability’ in SPSS.
 Step 6: Inspection of Overlap and Exclusion of
Non-Overlapping Cases 
 For the short-term treatment group (n = 331), the PS 
ranged between 0.03 and 0.98; for the long-term treat-
ment group (n = 328), the PS ranged between 0.10 and 
0.99 (see  fig. 1 ). The PS range that both groups cover is 
between 0.10 and 0.98. Patients with a PS outside this 
common range (n = 24) were excluded from the stratifi-
cation, leaving a sample of 635 patients.
 Step 7: Stratification of the Sample Based on the PS 
 The sample of 635 patients was divided into 5 equal 
subgroups with similar PS (so-called ‘strata’  [51] , see  ta-
ble 3 ). We then created 4 dummy variables based on these 
5 groups.
 Step 8: Balance Check after Correction 
 We needed to know if the stratification of the sample 
based on the PS resulted in a balance of pretreatment 
variables between the 2 treatment groups. Therefore, we 
checked again for differences in pretreatment variables. 
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This might be done for instance by comparing groups per 
stratum, but to keep in line with the illustrative analyses 
of step 2, we calculated the corrected differences between 
treatment groups by performing a number of regression 
analyses: this time with ‘group membership’ and the 4 
dummy variables indicating stratum membership as in-
dependent variables and pretreatment characteristics as 
dependent variables.    The    regression    coefficients    in    ta-
bles 1    and  2 (with stratum membership as covariate) in-
dicated that – on average across all strata – there were no 
longer significant differences in pretreatment variables. 
Our estimated PS seemed to balance, in a satisfactory 
way, the observed significant pretreatment differences 
between the short-term and the long-term groups. In case 
differences in pretreatment variables between groups are 
more persistent, one can try to re-estimate the PS, for in-
stance by including interaction terms or non-linear rela-
tionships and restart at step 5.
 Step 9: Effect Estimation after Correction 
 After taking into account the influence of known pre-
treatment characteristics using the PS, a corrected esti-
mate of the treatment effect can be calculated. This can 
be done in different statistical ways, for instance by 
weighting the 5 treatment effects of the different strata. 
To keep in line with our analysis in step 1, we used a lin-
ear regression analysis with the GSI as the dependent 
variable, but this time ‘group membership’ and the 4 
dummy variables indicating stratum membership were 
the independent variables. The effect of the treatment 
group on outcome was reduced from   = 0.20 (SE = 0.05; 
p  ! 0.001) before PS correction to   = 0.15 (SE = 0.06; 
p  ! 0.05) after PS correction. This shows that, when ob-
served pretreatment differences were not taken into ac-
count, the treatment effect was overestimated. Stratifica-
tion of the sample based on the PS reduced this bias.
 Alternatives to Stratification: PS in Regression 
Analysis and Matching 
 We present the results of 2 alternative methods for ad-
justing a treatment effect estimation using the PS.
 Regression Analysis 
 We performed a linear regression analysis with the 
GSI as the dependent variable, and the PS (as a continu-
ous covariate) and the variable ‘treatment group’ as inde-
pendent variables. After controlling for the PS by includ-
ing it as a covariate in the regression analysis, the effect 
of treatment group membership was reduced from   = 
0.20 (SE = 0.05; p  ! 0.001) before the correction to   = 
0.14 (SE = 0.06; p  ! 0.05) after the PS correction. This is 
similar to the result of adjustment by stratification.
 Matching 
 We matched each subject from the long-term group 
(this was the smallest group) with a subject from the 
short-term group, based on nearest available PS. Each 
subject from the short-term group only served once as 
matching partner for a subject from the long-term group 
(‘sampling without replacement’). To ensure similarity in 
the matched pairs we used ‘caliper matching’  [52] , i.e. all 
pairs with a PS difference larger than 0.10 were removed 
from the analysis. This meant only 179 matched pairs 
(358 individuals) remained in the analysis. After match-
ing, the 2 groups showed no difference on any of the ob-
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Table 3. Distribution of patients across the 5 strata
Stratum Short term Long term Total
1 104 23 127
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5 17 110 127
Total 309 326 635
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served pretreatment variables. To keep in line with our 
previous analyses, a regression analysis was conducted in 
the matched sample, with the GSI as the dependent vari-
able, and the variable ‘group membership’ as the inde-
pendent variable. The effect of treatment group member-
ship was reduced from   = 0.20 (SE = 0.05; p  ! 0.001) 
before matching to   = 0.15 (SE = 0.07; p  ! 0.05) after 
matching (alternatively, a paired t test might be conduct-
ed in the matched sample). Though our matching proce-
dure was successful in balancing and correcting for ob-
served pretreatment differences, we lost a substantial 
amount of information due to a reduced sample size. In 
other (bigger) samples, matching might still be a useful 
strategy to correct for overt bias, especially when the con-
trol pool is large.
 Discussion 
 Randomization in general and its application in psy-
chotherapy research have been criticized by different au-
thors for various reasons. Non-randomized studies, how-
ever, face the serious problem of selection bias. As a result, 
a need is felt for alternative and complementary research 
designs in the field of psychotherapy, like quasi-experi-
mental designs. The PS method offers a solution to one 
part of the problem, overt bias, by balancing the treat-
ment groups with regard to observed pretreatment differ-
ences. To overcome selection bias, the PS method offers 
advantages compared to traditional methods. First, the 
PS provides better insight in the selection process. Mod-
elling treatment selection in a logistic regression analysis 
clarifies which variables affect selection and to what de-
gree. Second, it is easier to match or stratify on a single 
score (like the PS) than on a range of pretreatment char-
acteristics. The same holds true for regression adjustment 
techniques. Use of the single score PS enhances statistical 
power, as compared to many covariates in a regression 
analysis. Third, both the overlap in the distribution of the 
PS and balance of baseline variables after correction can 
be investigated and used as a descriptive tool  [16] . The PS 
method, like any statistical correction method for selec-
tion bias, is only helpful given a considerable balance of 
baseline characteristics. After all, comparing very differ-
ent subject groups in an outcome study is irrelevant, both 
scientifically and clinically. The PS helps to identify sub-
jects differing widely on their pretreatment characteris-
tics (and, as a consequence, on their PS). Determining the 
(essential) overlap of the distributions and balance with 
classical covariate regression analysis is cumbersome and 
therefore probably rarely done. As a last advantage, we 
would mention that the PS method can be applied in dif-
ferent ways (stratification, matching, in a regression anal-
ysis). Therefore, it can be tailored to sample characteris-
tics and researchers’ insights and decisions. Obviously, 
the PS method is not without limitations and has to be 
used responsibly  [53] . A researcher using the PS should 
take into account the following recommendations. First, 
the PS only corrects for observed pretreatment character-
istics, not for unobserved (unknown) variables, hamper-
ing true cause-effect analysis. This is called the ‘ignor-
ability’ or ‘no unobserved confounders’ assumption. Even 
when using the PS carefully, results may still be biased 
due to unobserved variables. This is why, before starting 
a study, as many confounders as possible should be iden-
tified and measured in a reliable way. This reduces the 
risk that important variables are overlooked. It is recom-
mended to consult several experts from both the clinical 
and statistical field to gain insight into the most relevant 
pretreatment variables. Experts’ consensus and statistical 
relevance should guide the choice for potential confound-
ers. Interestingly, when prognostic factors are well under-
stood and controlled for, and inclusion/exclusion criteria 
are the same, randomized and nonrandomized studies 
can have similar outcomes  [54–56] . Second, be careful 
when selecting variables to estimate the PS. Brookhart et 
al.  [57] tested several ways of selecting relevant variables 
in a simulation study. Their findings suggest that all vari-
ables related to study outcome should be included in the 
PS model, whether or not these variables influence treat-
ment assignment. In this study, we followed their advice. 
However, in the field there is still discussion on which is 
the best method for selecting the variables for the PS 
model [e.g.  58 ]. Third, the sample size of a study has to be 
sufficiently large, especially for stratification purposes, to 
allow for a meaningful correction of bias by means of the 
PS. Otherwise, several strata might be populated exclu-
sively by patients with the same treatment condition, 
making comparison impossible. A high number of miss-
ing values on baseline variables causes problems as well. 
As the PS method uses a combination of many variables, 
just one missing variable leads to a missing PS, excluding 
this patient from all further analysis. Well-chosen impu-
tation methods can be used to fill in missing values and 
guarantee a sufficient sample size without losing statisti-
cal precision. The availability of all essential data is the 
first condition for a meaningful application of the PS 
method, just as for any other statistical correction meth-
od. We conclude that the PS method is a powerful way of 
simultaneously adjusting for many observed confound-
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ers in nonrandomized studies, thereby most probably re-
ducing bias in treatment comparisons. If used in a re-
sponsible and thoughtful way, the PS method used in 
quasi-experimentation offers a strong research design in 
situations where randomization is not possible. There-
fore, the PS method is a promising tool for future psycho-
therapy research.
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